The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Tuberculosis Diagnostic Market Research Report 2025
Synopsis
Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. The classic symptoms of active TB are a chronic cough with blood-containing sputum, fever, night sweats, and weight loss. The historical term "consumption" came about due to the weight loss. Infection of other organs can cause a wide range of symptoms.
The global Tuberculosis Diagnostic market was valued at US$ 2630 million in 2023 and is anticipated to reach US$ 3373.5 million by 2030, witnessing a CAGR of 3.5% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Tuberculosis Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tuberculosis Diagnostic.
Report Scope
The Tuberculosis Diagnostic market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Tuberculosis Diagnostic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tuberculosis Diagnostic companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
Hologic Corporation
Abbott
Becton Dickinson
Roche
bioMerieux
Sanofi
Cepheid
Hain Lifescience
QIAGEN
Segment by Type
Radiographic Method
Diagnostic Laboratory Methods
Nucleic Acid Testing
Phage Assay
Detection of Latent Infection
Cytokine Detection Assay
Detection of Drug Resistance
Segment by Application
Infants
Adults
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Tuberculosis Diagnostic companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. The classic symptoms of active TB are a chronic cough with blood-containing sputum, fever, night sweats, and weight loss. The historical term "consumption" came about due to the weight loss. Infection of other organs can cause a wide range of symptoms.
The global Tuberculosis Diagnostic market was valued at US$ 2630 million in 2023 and is anticipated to reach US$ 3373.5 million by 2030, witnessing a CAGR of 3.5% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Tuberculosis Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tuberculosis Diagnostic.
Report Scope
The Tuberculosis Diagnostic market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Tuberculosis Diagnostic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tuberculosis Diagnostic companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
Hologic Corporation
Abbott
Becton Dickinson
Roche
bioMerieux
Sanofi
Cepheid
Hain Lifescience
QIAGEN
Segment by Type
Radiographic Method
Diagnostic Laboratory Methods
Nucleic Acid Testing
Phage Assay
Detection of Latent Infection
Cytokine Detection Assay
Detection of Drug Resistance
Segment by Application
Infants
Adults
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Tuberculosis Diagnostic companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tuberculosis Diagnostic Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Radiographic Method
1.2.3 Diagnostic Laboratory Methods
1.2.4 Nucleic Acid Testing
1.2.5 Phage Assay
1.2.6 Detection of Latent Infection
1.2.7 Cytokine Detection Assay
1.2.8 Detection of Drug Resistance
1.3 Market by Application
1.3.1 Global Tuberculosis Diagnostic Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Infants
1.3.3 Adults
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Tuberculosis Diagnostic Market Perspective (2019-2030)
2.2 Tuberculosis Diagnostic Growth Trends by Region
2.2.1 Global Tuberculosis Diagnostic Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Tuberculosis Diagnostic Historic Market Size by Region (2019-2024)
2.2.3 Tuberculosis Diagnostic Forecasted Market Size by Region (2025-2030)
2.3 Tuberculosis Diagnostic Market Dynamics
2.3.1 Tuberculosis Diagnostic Industry Trends
2.3.2 Tuberculosis Diagnostic Market Drivers
2.3.3 Tuberculosis Diagnostic Market Challenges
2.3.4 Tuberculosis Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tuberculosis Diagnostic Players by Revenue
3.1.1 Global Top Tuberculosis Diagnostic Players by Revenue (2019-2024)
3.1.2 Global Tuberculosis Diagnostic Revenue Market Share by Players (2019-2024)
3.2 Global Tuberculosis Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Tuberculosis Diagnostic Revenue
3.4 Global Tuberculosis Diagnostic Market Concentration Ratio
3.4.1 Global Tuberculosis Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tuberculosis Diagnostic Revenue in 2023
3.5 Tuberculosis Diagnostic Key Players Head office and Area Served
3.6 Key Players Tuberculosis Diagnostic Product Solution and Service
3.7 Date of Enter into Tuberculosis Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Tuberculosis Diagnostic Breakdown Data by Type
4.1 Global Tuberculosis Diagnostic Historic Market Size by Type (2019-2024)
4.2 Global Tuberculosis Diagnostic Forecasted Market Size by Type (2025-2030)
5 Tuberculosis Diagnostic Breakdown Data by Application
5.1 Global Tuberculosis Diagnostic Historic Market Size by Application (2019-2024)
5.2 Global Tuberculosis Diagnostic Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Tuberculosis Diagnostic Market Size (2019-2030)
6.2 North America Tuberculosis Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Tuberculosis Diagnostic Market Size by Country (2019-2024)
6.4 North America Tuberculosis Diagnostic Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Tuberculosis Diagnostic Market Size (2019-2030)
7.2 Europe Tuberculosis Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Tuberculosis Diagnostic Market Size by Country (2019-2024)
7.4 Europe Tuberculosis Diagnostic Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Tuberculosis Diagnostic Market Size (2019-2030)
8.2 Asia-Pacific Tuberculosis Diagnostic Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Tuberculosis Diagnostic Market Size by Region (2019-2024)
8.4 Asia-Pacific Tuberculosis Diagnostic Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Tuberculosis Diagnostic Market Size (2019-2030)
9.2 Latin America Tuberculosis Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Tuberculosis Diagnostic Market Size by Country (2019-2024)
9.4 Latin America Tuberculosis Diagnostic Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Tuberculosis Diagnostic Market Size (2019-2030)
10.2 Middle East & Africa Tuberculosis Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Tuberculosis Diagnostic Market Size by Country (2019-2024)
10.4 Middle East & Africa Tuberculosis Diagnostic Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Tuberculosis Diagnostic Introduction
11.1.4 Thermo Fisher Scientific Revenue in Tuberculosis Diagnostic Business (2019-2024)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Hologic Corporation
11.2.1 Hologic Corporation Company Detail
11.2.2 Hologic Corporation Business Overview
11.2.3 Hologic Corporation Tuberculosis Diagnostic Introduction
11.2.4 Hologic Corporation Revenue in Tuberculosis Diagnostic Business (2019-2024)
11.2.5 Hologic Corporation Recent Development
11.3 Abbott
11.3.1 Abbott Company Detail
11.3.2 Abbott Business Overview
11.3.3 Abbott Tuberculosis Diagnostic Introduction
11.3.4 Abbott Revenue in Tuberculosis Diagnostic Business (2019-2024)
11.3.5 Abbott Recent Development
11.4 Becton Dickinson
11.4.1 Becton Dickinson Company Detail
11.4.2 Becton Dickinson Business Overview
11.4.3 Becton Dickinson Tuberculosis Diagnostic Introduction
11.4.4 Becton Dickinson Revenue in Tuberculosis Diagnostic Business (2019-2024)
11.4.5 Becton Dickinson Recent Development
11.5 Roche
11.5.1 Roche Company Detail
11.5.2 Roche Business Overview
11.5.3 Roche Tuberculosis Diagnostic Introduction
11.5.4 Roche Revenue in Tuberculosis Diagnostic Business (2019-2024)
11.5.5 Roche Recent Development
11.6 bioMerieux
11.6.1 bioMerieux Company Detail
11.6.2 bioMerieux Business Overview
11.6.3 bioMerieux Tuberculosis Diagnostic Introduction
11.6.4 bioMerieux Revenue in Tuberculosis Diagnostic Business (2019-2024)
11.6.5 bioMerieux Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Detail
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Tuberculosis Diagnostic Introduction
11.7.4 Sanofi Revenue in Tuberculosis Diagnostic Business (2019-2024)
11.7.5 Sanofi Recent Development
11.8 Cepheid
11.8.1 Cepheid Company Detail
11.8.2 Cepheid Business Overview
11.8.3 Cepheid Tuberculosis Diagnostic Introduction
11.8.4 Cepheid Revenue in Tuberculosis Diagnostic Business (2019-2024)
11.8.5 Cepheid Recent Development
11.9 Hain Lifescience
11.9.1 Hain Lifescience Company Detail
11.9.2 Hain Lifescience Business Overview
11.9.3 Hain Lifescience Tuberculosis Diagnostic Introduction
11.9.4 Hain Lifescience Revenue in Tuberculosis Diagnostic Business (2019-2024)
11.9.5 Hain Lifescience Recent Development
11.10 QIAGEN
11.10.1 QIAGEN Company Detail
11.10.2 QIAGEN Business Overview
11.10.3 QIAGEN Tuberculosis Diagnostic Introduction
11.10.4 QIAGEN Revenue in Tuberculosis Diagnostic Business (2019-2024)
11.10.5 QIAGEN Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Tuberculosis Diagnostic Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Radiographic Method
Table 3. Key Players of Diagnostic Laboratory Methods
Table 4. Key Players of Nucleic Acid Testing
Table 5. Key Players of Phage Assay
Table 6. Key Players of Detection of Latent Infection
Table 7. Key Players of Cytokine Detection Assay
Table 8. Key Players of Detection of Drug Resistance
Table 9. Global Tuberculosis Diagnostic Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global Tuberculosis Diagnostic Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 11. Global Tuberculosis Diagnostic Market Size by Region (2019-2024) & (US$ Million)
Table 12. Global Tuberculosis Diagnostic Market Share by Region (2019-2024)
Table 13. Global Tuberculosis Diagnostic Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 14. Global Tuberculosis Diagnostic Market Share by Region (2025-2030)
Table 15. Tuberculosis Diagnostic Market Trends
Table 16. Tuberculosis Diagnostic Market Drivers
Table 17. Tuberculosis Diagnostic Market Challenges
Table 18. Tuberculosis Diagnostic Market Restraints
Table 19. Global Tuberculosis Diagnostic Revenue by Players (2019-2024) & (US$ Million)
Table 20. Global Tuberculosis Diagnostic Market Share by Players (2019-2024)
Table 21. Global Top Tuberculosis Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis Diagnostic as of 2023)
Table 22. Ranking of Global Top Tuberculosis Diagnostic Companies by Revenue (US$ Million) in 2023
Table 23. Global 5 Largest Players Market Share by Tuberculosis Diagnostic Revenue (CR5 and HHI) & (2019-2024)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Tuberculosis Diagnostic Product Solution and Service
Table 26. Date of Enter into Tuberculosis Diagnostic Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Tuberculosis Diagnostic Market Size by Type (2019-2024) & (US$ Million)
Table 29. Global Tuberculosis Diagnostic Revenue Market Share by Type (2019-2024)
Table 30. Global Tuberculosis Diagnostic Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 31. Global Tuberculosis Diagnostic Revenue Market Share by Type (2025-2030)
Table 32. Global Tuberculosis Diagnostic Market Size by Application (2019-2024) & (US$ Million)
Table 33. Global Tuberculosis Diagnostic Revenue Market Share by Application (2019-2024)
Table 34. Global Tuberculosis Diagnostic Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 35. Global Tuberculosis Diagnostic Revenue Market Share by Application (2025-2030)
Table 36. North America Tuberculosis Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. North America Tuberculosis Diagnostic Market Size by Country (2019-2024) & (US$ Million)
Table 38. North America Tuberculosis Diagnostic Market Size by Country (2025-2030) & (US$ Million)
Table 39. Europe Tuberculosis Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 40. Europe Tuberculosis Diagnostic Market Size by Country (2019-2024) & (US$ Million)
Table 41. Europe Tuberculosis Diagnostic Market Size by Country (2025-2030) & (US$ Million)
Table 42. Asia-Pacific Tuberculosis Diagnostic Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 43. Asia-Pacific Tuberculosis Diagnostic Market Size by Region (2019-2024) & (US$ Million)
Table 44. Asia-Pacific Tuberculosis Diagnostic Market Size by Region (2025-2030) & (US$ Million)
Table 45. Latin America Tuberculosis Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Latin America Tuberculosis Diagnostic Market Size by Country (2019-2024) & (US$ Million)
Table 47. Latin America Tuberculosis Diagnostic Market Size by Country (2025-2030) & (US$ Million)
Table 48. Middle East & Africa Tuberculosis Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 49. Middle East & Africa Tuberculosis Diagnostic Market Size by Country (2019-2024) & (US$ Million)
Table 50. Middle East & Africa Tuberculosis Diagnostic Market Size by Country (2025-2030) & (US$ Million)
Table 51. Thermo Fisher Scientific Company Detail
Table 52. Thermo Fisher Scientific Business Overview
Table 53. Thermo Fisher Scientific Tuberculosis Diagnostic Product
Table 54. Thermo Fisher Scientific Revenue in Tuberculosis Diagnostic Business (2019-2024) & (US$ Million)
Table 55. Thermo Fisher Scientific Recent Development
Table 56. Hologic Corporation Company Detail
Table 57. Hologic Corporation Business Overview
Table 58. Hologic Corporation Tuberculosis Diagnostic Product
Table 59. Hologic Corporation Revenue in Tuberculosis Diagnostic Business (2019-2024) & (US$ Million)
Table 60. Hologic Corporation Recent Development
Table 61. Abbott Company Detail
Table 62. Abbott Business Overview
Table 63. Abbott Tuberculosis Diagnostic Product
Table 64. Abbott Revenue in Tuberculosis Diagnostic Business (2019-2024) & (US$ Million)
Table 65. Abbott Recent Development
Table 66. Becton Dickinson Company Detail
Table 67. Becton Dickinson Business Overview
Table 68. Becton Dickinson Tuberculosis Diagnostic Product
Table 69. Becton Dickinson Revenue in Tuberculosis Diagnostic Business (2019-2024) & (US$ Million)
Table 70. Becton Dickinson Recent Development
Table 71. Roche Company Detail
Table 72. Roche Business Overview
Table 73. Roche Tuberculosis Diagnostic Product
Table 74. Roche Revenue in Tuberculosis Diagnostic Business (2019-2024) & (US$ Million)
Table 75. Roche Recent Development
Table 76. bioMerieux Company Detail
Table 77. bioMerieux Business Overview
Table 78. bioMerieux Tuberculosis Diagnostic Product
Table 79. bioMerieux Revenue in Tuberculosis Diagnostic Business (2019-2024) & (US$ Million)
Table 80. bioMerieux Recent Development
Table 81. Sanofi Company Detail
Table 82. Sanofi Business Overview
Table 83. Sanofi Tuberculosis Diagnostic Product
Table 84. Sanofi Revenue in Tuberculosis Diagnostic Business (2019-2024) & (US$ Million)
Table 85. Sanofi Recent Development
Table 86. Cepheid Company Detail
Table 87. Cepheid Business Overview
Table 88. Cepheid Tuberculosis Diagnostic Product
Table 89. Cepheid Revenue in Tuberculosis Diagnostic Business (2019-2024) & (US$ Million)
Table 90. Cepheid Recent Development
Table 91. Hain Lifescience Company Detail
Table 92. Hain Lifescience Business Overview
Table 93. Hain Lifescience Tuberculosis Diagnostic Product
Table 94. Hain Lifescience Revenue in Tuberculosis Diagnostic Business (2019-2024) & (US$ Million)
Table 95. Hain Lifescience Recent Development
Table 96. QIAGEN Company Detail
Table 97. QIAGEN Business Overview
Table 98. QIAGEN Tuberculosis Diagnostic Product
Table 99. QIAGEN Revenue in Tuberculosis Diagnostic Business (2019-2024) & (US$ Million)
Table 100. QIAGEN Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Tuberculosis Diagnostic Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Tuberculosis Diagnostic Market Share by Type: 2023 VS 2030
Figure 3. Radiographic Method Features
Figure 4. Diagnostic Laboratory Methods Features
Figure 5. Nucleic Acid Testing Features
Figure 6. Phage Assay Features
Figure 7. Detection of Latent Infection Features
Figure 8. Cytokine Detection Assay Features
Figure 9. Detection of Drug Resistance Features
Figure 10. Global Tuberculosis Diagnostic Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 11. Global Tuberculosis Diagnostic Market Share by Application: 2023 VS 2030
Figure 12. Infants Case Studies
Figure 13. Adults Case Studies
Figure 14. Tuberculosis Diagnostic Report Years Considered
Figure 15. Global Tuberculosis Diagnostic Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 16. Global Tuberculosis Diagnostic Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Tuberculosis Diagnostic Market Share by Region: 2023 VS 2030
Figure 18. Global Tuberculosis Diagnostic Market Share by Players in 2023
Figure 19. Global Top Tuberculosis Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis Diagnostic as of 2023)
Figure 20. The Top 10 and 5 Players Market Share by Tuberculosis Diagnostic Revenue in 2023
Figure 21. North America Tuberculosis Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. North America Tuberculosis Diagnostic Market Share by Country (2019-2030)
Figure 23. United States Tuberculosis Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Canada Tuberculosis Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Tuberculosis Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Tuberculosis Diagnostic Market Share by Country (2019-2030)
Figure 27. Germany Tuberculosis Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. France Tuberculosis Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. U.K. Tuberculosis Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Italy Tuberculosis Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Russia Tuberculosis Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Nordic Countries Tuberculosis Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Tuberculosis Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Tuberculosis Diagnostic Market Share by Region (2019-2030)
Figure 35. China Tuberculosis Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Japan Tuberculosis Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. South Korea Tuberculosis Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Southeast Asia Tuberculosis Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. India Tuberculosis Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Australia Tuberculosis Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Tuberculosis Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Tuberculosis Diagnostic Market Share by Country (2019-2030)
Figure 43. Mexico Tuberculosis Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Brazil Tuberculosis Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Tuberculosis Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Tuberculosis Diagnostic Market Share by Country (2019-2030)
Figure 47. Turkey Tuberculosis Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Saudi Arabia Tuberculosis Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Thermo Fisher Scientific Revenue Growth Rate in Tuberculosis Diagnostic Business (2019-2024)
Figure 50. Hologic Corporation Revenue Growth Rate in Tuberculosis Diagnostic Business (2019-2024)
Figure 51. Abbott Revenue Growth Rate in Tuberculosis Diagnostic Business (2019-2024)
Figure 52. Becton Dickinson Revenue Growth Rate in Tuberculosis Diagnostic Business (2019-2024)
Figure 53. Roche Revenue Growth Rate in Tuberculosis Diagnostic Business (2019-2024)
Figure 54. bioMerieux Revenue Growth Rate in Tuberculosis Diagnostic Business (2019-2024)
Figure 55. Sanofi Revenue Growth Rate in Tuberculosis Diagnostic Business (2019-2024)
Figure 56. Cepheid Revenue Growth Rate in Tuberculosis Diagnostic Business (2019-2024)
Figure 57. Hain Lifescience Revenue Growth Rate in Tuberculosis Diagnostic Business (2019-2024)
Figure 58. QIAGEN Revenue Growth Rate in Tuberculosis Diagnostic Business (2019-2024)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
